HomeInsightsStock Comparison

Centenial Surgical Suture Ltd vs Indraprastha Medical Corporation Ltd Stock Comparison

Centenial Surgical Suture Ltd vs Indraprastha Medical Corporation Ltd Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

  • The Latest Trading Price of Centenial Surgical Suture Ltd is ₹ 71.25 as of 26 Oct 15:30 . The P/E Ratio of Centenial Surgical Suture Ltd changed from 24.1 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Indraprastha Medical Corporation Ltd changed from 215 on March 2021 to 18.5 on March 2026 . This represents a CAGR of -33.56% over 6 years The Market Cap of Centenial Surgical Suture Ltd changed from ₹ 15.6 crore on March 2021 to ₹ 27.83 crore on March 2026 . This represents a CAGR of 10.13% over 6 yearsThe Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 492.74 crore on March 2021 to ₹ 3407 crore on March 2026 . This represents a CAGR of 38.03% over 6 years The revenue of Centenial Surgical Suture Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 15.35 crore. This represent the decline of -100% The revenue of Indraprastha Medical Corporation Ltd for the Sep '26 is ₹ 421.4 crore as compare to the Jun '26 revenue of ₹ 414.57 crore. This represent the growth of 1.65% The ebitda of Centenial Surgical Suture Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 2.19 crore. This represent the decline of -100% The ebitda of Indraprastha Medical Corporation Ltd for the Sep '26 is ₹ 85.99 crore as compare to the Jun '26 ebitda of ₹ 88.23 crore. This represent the decline of -2.54% The net profit of Centenial Surgical Suture Ltd changed from ₹ 0.3 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 44.77 crore to ₹ 53.58 crore over 10 quarters. This represents a CAGR of 7.45% The Dividend Payout of Centenial Surgical Suture Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 years .

About Centenial Surgical Suture Ltd

  • Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India.
  • The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes.
  • It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons.
  • Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company.

About Indraprastha Medical Corporation Ltd

  • Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
  • The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
  • The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
  • Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
  • IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

FAQs for the comparison of Centenial Surgical Suture Ltd and Indraprastha Medical Corporation Ltd

Which company has a larger market capitalization, Centenial Surgical Suture Ltd or Indraprastha Medical Corporation Ltd?

Market cap of Centenial Surgical Suture Ltd is 25 Cr while Market cap of Indraprastha Medical Corporation Ltd is 2,797 Cr

What are the key factors driving the stock performance of Centenial Surgical Suture Ltd and Indraprastha Medical Corporation Ltd?

The stock performance of Centenial Surgical Suture Ltd and Indraprastha Medical Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Centenial Surgical Suture Ltd and Indraprastha Medical Corporation Ltd?

As of October 31, 2026, the Centenial Surgical Suture Ltd stock price is INR ₹71.25. On the other hand, Indraprastha Medical Corporation Ltd stock price is INR ₹305.15.

How do dividend payouts of Centenial Surgical Suture Ltd and Indraprastha Medical Corporation Ltd compare?

To compare the dividend payouts of Centenial Surgical Suture Ltd and Indraprastha Medical Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions